Dr. Brian T. Hill
Claim this profileCleveland Clinic Foundation
Studies Lymphoma
Studies Chronic Lymphocytic Leukemia
9 reported clinical trials
13 drugs studied
Area of expertise
1Lymphoma
CD19 positive
CD20 positive
13q positive
2Chronic Lymphocytic Leukemia
CD19 positive
CD20 positive
13q positive
Affiliated Hospitals
Clinical Trials Brian T. Hill is currently running
Loncastuximab Tesirine + Venetoclax
for Non-Hodgkin's Lymphoma
The purpose of this study is to determine the correct dose and safety of combining two new cancer drugs, loncastuximab tesirine and venetoclax, as a treatment for relapsed or refractory B cell lymphoma.These drugs are used to treat some lymphomas, but have not yet been tested in combination for the treatment of lymphoma. The main goal of this study is to determine the safety of the combination.
Recruiting1 award Phase 1
GM T Cell Therapy Long-Term Follow-Up
for Cancer
This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least one infusion of GM T cells will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.
Recruiting1 award Phase 2 & 3
More about Brian T. Hill
Clinical Trial Related6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Brian T. Hill has experience with
- Venetoclax
- Obinutuzumab
- NKX019
- Fludarabine
- Cyclophosphamide
- JCAR017
Breakdown of trials Brian T. Hill has run
Lymphoma
Chronic Lymphocytic Leukemia
Mixed-Cell Lymphoma
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian T. Hill specialize in?
Brian T. Hill focuses on Lymphoma and Chronic Lymphocytic Leukemia. In particular, much of their work with Lymphoma has involved CD19 positive patients, or patients who are CD20 positive.
Is Brian T. Hill currently recruiting for clinical trials?
Yes, Brian T. Hill is currently recruiting for 3 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Brian T. Hill has studied deeply?
Yes, Brian T. Hill has studied treatments such as Venetoclax, Obinutuzumab, NKX019.
What is the best way to schedule an appointment with Brian T. Hill?
Apply for one of the trials that Brian T. Hill is conducting.
What is the office address of Brian T. Hill?
The office of Brian T. Hill is located at: Cleveland Clinic Foundation, Cleveland, Ohio 44195 United States. This is the address for their practice at the Cleveland Clinic Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.